dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Azanza, Jose Ramon |
dc.contributor.author | Ruiz Camps, Isabel |
dc.contributor.author | Vallejo, Carlos |
dc.contributor.author | Mensa, Josep |
dc.contributor.author | Maertens, Johan |
dc.contributor.author | Grau, Santiago |
dc.date.accessioned | 2021-04-22T08:19:43Z |
dc.date.available | 2021-04-22T08:19:43Z |
dc.date.copyright | 2017 |
dc.date.issued | 2016-12-30 |
dc.identifier.citation | Grau S, Azanza JR, Ruiz I, Vallejo C, Mensa J, Maertens J, et al. Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain. Clin Outcomes Res. 2016 Dec 30;Volume 9:39–47. |
dc.identifier.issn | 1178-6981 |
dc.identifier.uri | https://hdl.handle.net/11351/5897 |
dc.description | Anidulafungina; Cost-efectivitat; Aspergil·losi invasiva |
dc.language.iso | eng |
dc.publisher | Dove Medical Press |
dc.relation.ispartofseries | ClinicoEconomics and Outcomes Research;9 |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Assistència sanitària - Cost - Catalunya |
dc.subject | Sang - Malalties |
dc.subject | Medicaments |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Costs and Cost Analysis |
dc.subject.mesh | Hematologic Diseases |
dc.subject.mesh | Spain |
dc.title | Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.2147/CEOR.S122177 |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | costes y análisis de costes |
dc.subject.decs | enfermedades hematológicas |
dc.subject.decs | España |
dc.relation.publishversion | https://www.dovepress.com/cost-effectiveness-analysis-of-combination-antifungal-therapy-with-vor-peer-reviewed-article-CEOR |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Grau S] Pharmacy Department, Hospital del Mar, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Azanza JR] Clinical Pharmacology Department, Clínica Universidad de Navarra, Pamplona. [Ruiz I] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Vallejo C] Hematology Department, Hospital Universitario Donostia, San Sebastián. [Mensa J] Infectious Diseases Department, Hospital Clínic de Barcelona, Barcelona, Spain. [Maertens J] Hematology Department, University Hospital Gasthuisberg, Leuven, Belgium |
dc.identifier.pmid | 28115858 |
dc.identifier.wos | 000391475500002 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |